Obsessive Compulsive Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: OCD patient 1.Subjects with primary diagnosis of obsessive compulsive disorder by DSM-5. 2.Those who have 16 or more CY-BOCS 3.Aged 12 years or older, and younger than 17 years at screening. 4.Subjects who give consent with not to change current pharmacotherapy. 5.Subjects who give full consent in the participation of the study. Patient's family 1. One family member living with the patient for at least one year at the time of screening. The family members are primarily responsible for childcare or are most involved in patient OCD. 2. Subjects who give full consent in the participation of the study.
Exclusion criteria
Exclusion criteria: 1.No alcohol or substance use disorder in 6 months prior to the screening. 2.No other primary Disorders in 6 months prior to the screening. 3.No serious suicidal ideation at screening. 4.Patients with IQ less than 70 5.Persons who have adjusted their drugs for 12 weeks before screening 6.Patients who are difficult to visit 14 times after screening 7.Patients whose family members are difficult to participate in all five family program sessions during CBT 8.Those who have received CBT for structured obsessive-compulsive disorder by the time of screening 9.Those who have severe cognitive impairment that makes it difficult to perform CBT at the time of screening 10.Those who have a serious or unstable physical disease that is life-threatening in clinical diagnosis at the time of screening 11.Those who are deemed inappropriate by the research supervisor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CY-BOCS;Child Yale Brown Obsessive Compulsive Scale at the time of end of intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.FAS;Family Accommodation Scale 2.OFF;OCD Family Functioning Scale 3.CGI-S;Impairment 4.CGI-S;Improvement 5.CBCL;Child Behavior Checklist, YSR;Youth Self-Report | — |
Countries
Japan
Contacts
Kanazawa University Department of Psychiatry and Neurobiology